The CEO of French consumer goods giant Danone on Wednesday downplayed the threat of obesity drugs on its food business.

"Danone is now stronger, more resilient. The company is ready for more challenges," CEO Antoine de Saint-Affrique said. When asked how Danone would use some of the 3 billion euros ($3.15 billion) in ...

Q: What is Danone's outlook on raw material costs and pricing for 2025, and why did specialized nutrition pricing turn negative in Q4? A: Antoine de Saint-Affrique, CEO, explained that Danone ...

As Lifeway Foods and Danone battle it out, a family feud continues to fester at the US firm, between its chair and CEO Julie Smolyansky, and her mother and brother, Ludmila and Edward Smolyansky, ...

Lifeway Foods has reached an inflection point. The Board's continued deference to the CEO has raised serious governance concerns, and it must now demonstrate in court that its actions align with its ...

Mathilde Rodié speaking. Thank you for being with us this morning for Danone’s 2024 Full Year Results Call. I’m here with our CEO, Antoine de Saint-Affrique; and our CFO, Juergen Esser ...

PARIS — Danone SA returned to volume/mix growth in ... under the Activia brand,” said Juergen Esser, group deputy CEO in charge of finance, technology and data. The high protein levels of ...

said CEO Antoine de Saint-Affrique. Fourth quarter sales contributed significantly to Danone’s final ratings, with total value and volume sales up 4.7% and 4.2% respectively over the period. All of ...

Danone’s overarching strategy geared toward consumer health is also likely to benefit from the increasing use of the GLP-1 weight-loss drugs in the US, the CEO suggested, with a passing ...

"Danone is now stronger, more resilient. The company is ready for more challenges," CEO Antoine de Saint-Affrique said. When asked how Danone would use some of the 3 billion euros ($3.15 billion ...